Interestingly, previous evidences showed that ICS II could relieve neuroinflammation by suppressing NF-κB activation to exert the neuroprotective effect on middle cerebral artery occlusion (MCAO)-induced cognitive deficits in rats (Deng et al., 2016). The gene discussed is NFKB1; the disease is Cognitive impairment.